Cost effectiveness analyses have been carried out in Sweden

BMJ

Volumn 313, Issue 7066, 1996, Pages 1203-1204

  Lindholm, Lars H ^a   Werko, Lars ^b  

^a LUND UNIVERSITY   (Sweden)

^b Swedish Council on Technology Assessment in Health Care   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLOOD PRESSURE; COST BENEFIT ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NOTE; PRACTICE GUIDELINE; SWEDEN; BLOOD PRESSURE MONITORING; COST EFFECTIVENESS ANALYSIS; DIASTOLIC BLOOD PRESSURE; GENERAL PRACTICE; LETTER; MEDICAL AUDIT; PRIORITY JOURNAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING;

ADULT; AGED; BLOOD PRESSURE; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRACTICE GUIDELINES; SWEDEN;

ANTIHYPERTENSIVE AGENT;

EID: 0041119236     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.313.7066.1203b     Document Type: Letter

References (3)

1. Fahey TP, Peters TJ What constitutes controlled hypertension? Patient based comparison of hypertension guidelines. BMJ 1996; 313: 93–6. (13 July.)
2. Jackson RT, Sackett DL Guidelines for managing raised blood pressure. BMJ 1996; 313: 64–5. (13 July.)
3. Swedish Council on Technology Assessment in Health Care Moderately elevated blood pressure. J Intern Med 1996; 238 (suppl 737): 1–225.